期刊
MOLECULAR MEDICINE REPORTS
卷 17, 期 3, 页码 3769-3774出版社
SPANDIDOS PUBL LTD
DOI: 10.3892/mmr.2017.8326
关键词
mouse mesenchymal stem cells; non-alcoholic fatty liver disease; high-fat diet; T cells
资金
- One College One Policy Project, Modern College of Arts and Science, Shanxi Normal University
- Scientific Research Foundation for Doctors, Shanxi Normal University [0505/02070293]
Although the multipotency of mesenchymal stem cells (MSCs) makes them an attractive choice for clinical applications, immune modulation is an important factor affecting MSC transplantation. At present, the effect of treatment with MSCs on non-alcoholic fatty liver disease (NAFLD) has received little attention. In the present study, a compact bone-derived method was used to isolate mouse MSCs (mMSCs) and a high-fat diet was used to establish a mouse model of NAFLD. Immunophenotypic features of mMSCs were analyzed using flow cytometry. Paraffin sections were stained with hematoxylin and eosin to assess inflammation and steatosis, and with picrosirius red to assess fibrosis. Spleen leukocytes were analyzed by flow cytometry. The results demonstrated that compact bone-derived MSC transplantation decreased high-fat diet-induced weight gain, expansion of subcutaneous adipose tissue, steatosis, lobular inflammation and liver fibrogenesis. Flow cytometry analysis of spleen leukocytes demonstrated that compact bone-derived MSC transplantation suppressed the proliferation of cluster of differentiation (CD) 4(+) T lymphocytes in the spleen, which had been induced by the high-fat diet. In conclusion, compact bone-derived MSCs may exhibit clinical value in the treatment of NAFLD through their capacity to suppress the activation of CD4(+) T cells.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据